UK Markets open in 5 hrs 2 mins

Puma Biotechnology, Inc. (PBYI)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
9.90+0.18 (+1.85%)
At close: 4:00PM EDT
9.90 0.00 (0.00%)
After hours: 04:55PM EDT
Currency in USD

Valuation measures

Market cap (intra-day) 5399.58M
Enterprise value 3408.03M
Trailing P/E N/A
Forward P/E 1-47.14
PEG ratio (5-yr expected) 1-0.32
Price/sales (ttm)1.47
Price/book (mrq)24.26
Enterprise value/revenue 31.50
Enterprise value/EBITDA 711.64

Trading information

Stock price history

Beta (5Y monthly) 1.28
52-week change 3N/A
S&P500 52-week change 3N/A
52-week high 314.14
52-week low 37.48
50-day moving average 310.39
200-day moving average 310.73

Share statistics

Avg vol (3-month) 3304.83k
Avg vol (10-day) 3481.96k
Shares outstanding 540.36M
Implied shares outstanding 6N/A
Float 29.71M
% held by insiders 113.48%
% held by institutions 195.72%
Shares short (27 May 2021) 43.86M
Short ratio (27 May 2021) 414.98
Short % of float (27 May 2021) 411.43%
Short % of shares outstanding (27 May 2021) 49.56%
Shares short (prior month 29 Apr 2021) 44.12M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 3N/A
Trailing annual dividend yield 3N/A
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 30 Dec 2020
Most-recent quarter (mrq)30 Mar 2021


Profit margin -9.75%
Operating margin (ttm)8.82%

Management effectiveness

Return on assets (ttm)6.20%
Return on equity (ttm)-205.58%

Income statement

Revenue (ttm)272.06M
Revenue per share (ttm)6.83
Quarterly revenue growth (yoy)91.70%
Gross profit (ttm)185.74M
Net income avi to common (ttm)-26.53M
Diluted EPS (ttm)-0.67
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)109.05M
Total cash per share (mrq)2.7
Total debt (mrq)121.13M
Total debt/equity (mrq)736.95
Current ratio (mrq)1.17
Book value per share (mrq)0.41

Cash flow statement

Operating cash flow (ttm)27.97M
Levered free cash flow (ttm)60.54M